Exacerbations in cystic fibrosis: 4--Non-cystic fibrosis bronchiectasis.

https://arctichealth.org/en/permalink/ahliterature158549
Source
Thorax. 2008 Mar;63(3):269-76
Publication Type
Article
Date
Mar-2008
Author
A B Chang
D. Bilton
Author Affiliation
Department of Respiratory Medicine, Royal Children's Hospital, Herston Road, Brisbane, Queensland 4029, Australia. annechang@ausdoctors.net
Source
Thorax. 2008 Mar;63(3):269-76
Date
Mar-2008
Language
English
Publication Type
Article
Keywords
Acute Disease
Antibodies - therapeutic use
Biological Markers - analysis
Biomedical research
Bronchiectasis - complications - diagnosis - prevention & control
Cystic Fibrosis - complications - diagnosis - prevention & control
Humans
Risk factors
Sputum - cytology
Abstract
Bronchiectasis unrelated to cystic fibrosis (CF) is increasingly recognised as an important and major primary respiratory disease in developing countries. In affluent countries, bronchiectasis is also increasingly recognised in subsections of communities (such as indigenous peoples) as well as a co-existent disease/co-morbidity and disease modifier in respiratory diseases such as chronic obstructive pulmonary disease. The epidemiology, pathogenesis, prevention and management of exacerbations of non-CF bronchiectasis are reviewed. There are few data on all aspects of exacerbations in bronchiectasis. Some of the management issues are common to non-CF and CF bronchiectasis, but it would be unwise to extrapolate from CF studies to non-CF bronchiectasis. In some situations this may be harmful.
PubMed ID
18308962 View in PubMed
Less detail